Comments
Loading...
Eloxx Pharmaceuticals Analyst Ratings and Price Targets | OTC:ELOX | Benzinga
Eloxx Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Eloxx Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Eloxx Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2023 | Buy Now | — | Oppenheimer | Hartaj Singh45% | $50 → $55 | Maintains | Outperform | Get Alert |
| 04/06/2023 | Buy Now | — | Oppenheimer | Hartaj Singh45% | → $50 | Reiterates | → Outperform | Get Alert |
| 05/23/2022 | Buy Now | — | Piper Sandler | Edward Tenthoff50% | $4 → $1.5 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Eloxx Pharmaceuticals (ELOX) stock?
The latest price target for Eloxx Pharmaceuticals (OTCEM:ELOX) was reported by Oppenheimer on July 11, 2023. The analyst firm set a price target for $55.00 expecting ELOX to fall to within 12 months (a possible NaN% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eloxx Pharmaceuticals (ELOX)?
The latest analyst rating for Eloxx Pharmaceuticals (OTCEM:ELOX) was provided by Oppenheimer, and Eloxx Pharmaceuticals maintained their outperform rating.
When was the last upgrade for Eloxx Pharmaceuticals (ELOX)?
There is no last upgrade for Eloxx Pharmaceuticals
When was the last downgrade for Eloxx Pharmaceuticals (ELOX)?
There is no last downgrade for Eloxx Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eloxx Pharmaceuticals (ELOX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eloxx Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eloxx Pharmaceuticals was filed on July 11, 2023 so you should expect the next rating to be made available sometime around July 11, 2024.
Is the Analyst Rating Eloxx Pharmaceuticals (ELOX) correct?
While ratings are subjective and will change, the latest Eloxx Pharmaceuticals (ELOX) rating was a maintained with a price target of $50.00 to $55.00. The current price Eloxx Pharmaceuticals (ELOX) is trading at is $undefined, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
